Jun 7 2012
Giving young children medicine once a month during the rainy season to
protect them against malaria could prevent tens of thousands of deaths
each year in some areas of Africa, according to new research.
A team of scientists analysed the potential impact of a new strategy to
control malaria in Africa which takes a similar approach to that used to
protect travellers going to malaria endemic areas and found that even
with moderate levels of coverage it could lead to significant public
health improvements.
Malaria experts see this new approach, called seasonal malaria
chemoprevention (SMC), as an exciting new tool in the fight against
malaria. The study highlights the areas of Africa where this approach
could be used most effectively and will assist deployment of this new
control measure where it is needed urgently.
The study, published in Nature Communications, was led by the London
School of Hygiene & Tropical Medicine and involved a collaboration of
researchers in the UK and Africa.
In some parts of Africa, malaria is only a major problem for a few
months of the year during and immediately after the rainy season. In
these areas, providing monthly courses of a cheap antimalarial drug
combination (sulphadoxine-pyrimethamine and amodiaquine) to young
children during the malaria transmission season when they are at highest
risk has been shown to prevent approximately 80% of severe and
uncomplicated malaria cases.
It has been found that large-scale administration of antimalarial
medicines once-per-month on repeated occasions can be carried out
successfully, that it is very safe and that it provides protection even
if children are sleeping under insecticide treated bed-nets. Currently,
the main approaches to malaria control are use of insecticide treated
bed-nets and spraying of homes with insecticide, combined with prompt
diagnostic testing and effective treatment of malaria patients with
artemisinin-based combination therapies.
Combining satellite maps of rainfall with information on the malaria
burden in different areas of Africa, the researchers identified the
regions where seasonal malaria chemoprevention would be useful and
cost-effective. The largest impact would be in countries of the Sahel
and sub-Sahel, a wide-belt of Africa ranging from The Gambia and Senegal
in the West to parts of Sudan in the East. Key countries are Nigeria,
Niger, Burkina Faso and Mali, where approximately 14 million children
under five are at risk in areas suitable for this approach.
Following a review of the evidence including these findings by its
Malaria Policy Advisory Committee, the World Health Organization (WHO)
recently formally recommended seasonal malaria chemoprevention as policy
for malaria control in the Sahel and sub-Sahel. Some of the countries in
West Africa identified in this study may wish to introduce SMC into
their national malaria control programmes.
The team also estimated the number of children at risk of malaria in
these areas, and the number of malaria cases and deaths that could be
prevented if seasonal malaria chemoprevention is widely used. There are
approximately 40 million children under five living in parts of Africa
suitable for SMC who could benefit from this intervention and around
150,000 childhood deaths from malaria each year. Making realistic rather
than optimistic assumptions about how many children could be reached and
how effective this approach would be, the researchers estimate that
around 11 million cases of malaria and approximately 50,000 deaths from
malaria could be prevented per year if SMC was fully implemented.
Lead author Dr Matt Cairns, of the London School of Hygiene and
Tropical Medicine, said: "Providing insecticide-treated nets is an
important way of protecting children from malaria, but in some areas it
isn't enough - children need additional methods of protection. We have
identified two large areas of Africa where monthly seasonal
chemoprevention could be an effective addition to existing approaches
that reduce exposure to mosquitoes. If this control measure could be
deployed widely it could prevent many millions of cases of malaria and
tens of thousands of deaths every year."
Professor Sir Brian Greenwood, one of the senior authors of the study
and a leading expert on malaria control, said: "Excitingly, this is
something that is available to put into action immediately, so children
will start to benefit from this approach now rather than in three or
five years- time. The key is to ensure that the promise becomes a
reality."
Dr Robert Newman, Director of the WHO Global Malaria Programme,
remarked: "This intervention has great potential to contribute towards
the achievement of the health-related Millennium Development Goals in
the Sahel sub-Region of Africa; the opportunity for policy adoption and
implementation should be seized quickly."
Source: London School of Hygiene & Tropical Medicine